Search Results1-18 of  18

  • DOSAKA (AKITA) Hirotoshi ID: 9000001292033

    Department of Medical Oncology, Hokkaido University Graduate School of Medicine (2004 from CiNii)

    Articles in CiNii:1

    • Paraneoplastic Cerebellar Degeneration (PCD) Associated with Squamous Cell Carcinoma of the Lung (2004)
  • DOSAKA AKITA Hirotoshi ID: 9000001345091

    Department of Medical Oncology, Hokkaido University Graduate School of Medicine (2007 from CiNii)

    Articles in CiNii:3

    • Expression of RCAS1 in human gastric carcinoma : A potential mechanism of immune escape (2004)
    • HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer (2007)
    • Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer (2006)
  • DOSAKA-AKITA Hirotoshi ID: 9000000564307

    Articles in CiNii:11

    • "Web-like Obstruction" - A Sign of Regional Complete Remission after Concurrent Chemoradiotherapy in Small Cell Lung Cancer (1996)
    • CD4^+ T cells in cancer stroma, not CD8^+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers (2003)
    • Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers (2003)
  • DOSAKA-AKITA Hirotoshi ID: 9000015677683

    Hokkaido University Graduate School of Medicine (2003 from CiNii)

    Articles in CiNii:1

    • Eighteen Novel Polymorphisms of the CYP2A13 Gene in Japanesse (2003)
  • DOSAKA-AKITA Hirotoshi ID: 9000257889758

    Hokkaido University Graduate School of Medicine (2003 from CiNii)

    Articles in CiNii:1

    • Eighteen Novel Polymorphisms of the CYP2A13 Gene in Japanese (2003)
  • DOSAKA-AKITA Hirotoshi ID: 9000003109780

    Dept. Internal Med., Hokkaido Univ. Med. Sch. (2000 from CiNii)

    Articles in CiNii:1

    • W1-2 Toxicological Significance of Genetic Polymorphism of Cytochrome P450 : Genetic Polymorphism of CYP2A6 and Lung Cancer Risk.(Proceedings of the 27th Annual Meeting) (2000)
  • Dosaka-Akita Hirotoshi ID: 9000004444983

    北海道大学第1内科 (2007 from CiNii)

    Articles in CiNii:18

    • Clinical features of intradural spinal cord metastases in primary lung cancer (2005)
    • A case of idiopathic nonspecific interstitial pneumonia and autoimmune hemolytic anemia after complete cure of polymyalgia rheumatica (2006)
    • S3-5 バーチャル気管支鏡及び気管支腔内超音波断層法の併用による診断と分子標的薬剤選択への応用(<シンポジウム3>Virtual Bronchoscopyの臨床応用)(第28回 日本呼吸器内視鏡学会総会) (2005)
  • Dosaka-Akita Hirotoshi ID: 9000019222384

    Articles in CiNii:1

    • ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin-αvβ3-Dependent Mechanisms (2012)
  • Dosaka-Akita Hirotoshi ID: 9000237783197

    Articles in CiNii:1

    • Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 (2012)
  • Dosaka-Akita Hirotoshi ID: 9000242347762

    Articles in CiNii:1

    • Assessment of early changes in H-3-fluorothymidine uptake after treatment with gefitinib in human tumor xenograft in comparison with Ki-67 and phospho-EGFR expression (2013)
  • Dosaka-Akita Hirotoshi ID: 9000337097707

    Articles in CiNii:1

    • Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells (2016)
  • Dosaka-Akita Hirotoshi ID: 9000340952792

    Articles in CiNii:1

    • Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients (2012)
  • Dosaka-Akita Hirotoshi ID: 9000351082600

    Articles in CiNii:1

    • Expression of Notch1 and Numb in small cell lung cancer (2017)
  • Dosaka-Akita Hirotoshi ID: 9000386436081

    Articles in CiNii:1

    • Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors (2017)
  • Dosaka-Akita Hirotoshi ID: 9000398646503

    Articles in CiNii:1

    • A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002) (2017)
  • Dosaka-Akita Hirotoshi ID: 9000399008811

    Articles in CiNii:1

    • Early prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment : a protocol for a non-randomized single-arm multicenter observational study (2018)
  • Dosaka-Akita Hirotoshi ID: 9000403271643

    Articles in CiNii:1

    • Clinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (2018)
  • Dosaka-Akita Hirotoshi ID: 9000403320330

    Articles in CiNii:1

    • A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101) (2018)
Page Top